| Literature DB >> 34142281 |
Dominique Ramp1, Floortje Mols2,3, Nicole Ezendam1,4, Sandra Beijer4, Martijn Bours5, Renate Winkels6, Jolanda de Vries1, Jaap C Seidell7, Ellen Kampman6, Meeke Hoedjes1.
Abstract
OBJECTIVE: Two-third of colorectal cancer (CRC) survivors are overweight or obese. Psychological distress and low health-related quality of life (HRQoL) may be barriers to improving diet. We aimed to assess associations between psychological distress and HRQoL and the need for dietary support in CRC survivors with overweight or obesity.Entities:
Keywords: Colorectal cancer; Dietary support; Health-related quality of life; Obesity; Overweight; Psychological distress
Mesh:
Year: 2021 PMID: 34142281 PMCID: PMC8550733 DOI: 10.1007/s00520-021-06306-6
Source DB: PubMed Journal: Support Care Cancer ISSN: 0941-4355 Impact factor: 3.603
Fig. 1Flowchart of study participants. For this study, cross-sectional data from a larger longitudinal study among colorectal cancer survivors was used. A flowchart of the participants in the longitudinal study has been published elsewhere [4]. This current study involves data obtained from survey 3 in December 2012
Sociodemographic, cancer-related, and health-related characteristics of colorectal cancer survivors with overweight (N = 756) with and without a need for dietary support
| Total | Need for support | No need for support | ||
|---|---|---|---|---|
| N (%) * | N (%) * | N (%) * | OR (95%CI) | |
| Age in years | ||||
| 31–64 | 216 (28.6) | 63 (39.4) | 153 (25.7) | 1 |
| 65–69 | 158 (20.9) | 26 (16.3) | 132 (22.1) | |
| 70–76 | 203 (26.9) | 43 (26.9) | 160 (26.8) | 0.65 (0.42–1.02) |
| 77–87 | 179 (23.7) | 28 (17.5) | 151 (25.3) | |
| Sex | ||||
| Male | 507 (67.1) | 94 (58.8) | 413 (69.3) | |
| Female | 249 (32.9) | 66 (41.2) | 183 (30.7) | 1 |
| Marital status | ||||
| Living without a partner | 150 (19.8) | 44 (27.8) | 106 (17.8) | |
| Living with a partner | 603 (79.8) | 114 (72.2) | 489 (82.2) | 1 |
| SES | ||||
| Low | 130 (17.2) | 37 (23.9) | 93 (16.5) | 1.62 (1.00–2.61) |
| Medium | 300 (39.7) | 61 (39.4) | 239 (42.2) | 1.04 (0.69–1.56) |
| High | 289 (38.2) | 57 (36.8) | 232 (41.1) | 1 |
| Tumor site | ||||
| Colon | 430 (56.9) | 87 (54.4) | 343 (57.6) | 0.88 (0.62–1.25) |
| Rectum | 326 (43.1) | 73 (45.6) | 253 (42.4) | 1 |
| Tumor stage at diagnosis | ||||
| Stage I | 220 (29.1) | 46 (29.9) | 174 (30.0) | 1 |
| Stage II | 250 (33.1) | 53 (34.4) | 197 (34.0) | 1.02 (0.65–1.59) |
| Stage III | 244 (32.3) | 52 (33.8) | 192 (33.1) | 1.02 (0.66–1.60) |
| Stage IV | 20 (2.6) | 3 (1.9) | 17 (2.9) | 0.67 (0.19–2.38) |
| Time since diagnoses in years | ||||
| (Mean (SD)) | 6.8 (2.7) | 6.8 (2.6) | 6.7 (2.8) | 1.02 (0.95–1.08) |
| Receiving follow-up care | ||||
| No | 188 (24.9) | 39 (24.8) | 149 (25.2) | 1 |
| Yes | 560 (74.1) | 118 (75.2) | 442 (74.8) | 1.02 (0.68–1.53) |
| Treatment | ||||
| Surgery only | 325 (43.0) | 67 (41.9) | 258 (43.4) | ** |
| Surgery + radio | 178 (23.5) | 39 (24.4) | 139 (23.4) | |
| Surgery + chemo | 172 (22.8) | 38 (23.8) | 134 (22.5) | |
| Surgery + radio + chemo | 78 (10.3) | 15 (9.4) | 63 (10.6) | |
| Chemotherapy only | 2 (0.3) | 1 (0.6) | 1 (0.2) | |
| Chemotherapy | ||||
| No | 504 (66.7) | 106 (66.3) | 398 (66.8) | 1 |
| Yes | 252 (33.3) | 54 (33.8) | 198 (33.2) | 1.02 (0.71–1.48) |
| Radiotherapy | ||||
| No | 500 (66.1) | 106 (66.3) | 394 (66.1) | 1 |
| Yes | 256 (33.9) | 54 (33.8) | 202 (33.9) | 0.99 (0.69–1.44) |
| Stoma | ||||
| No | 503 (66.5) | 98 (70.5) | 405 (76.3) | 1 |
| Yes | 167 (22.1) | 41 (29.5) | 126 (23.7) | 1.35 (0.89–2.04) |
| Diabetes | ||||
| No | 526 (69.6) | 94 (71.2) | 432 (83.1) | 1 |
| Yes | 126 (16.7) | 38 (28.8) | 88 (16.9) | |
| Degree of overweight | ||||
| Overweight | 542 (71.7) | 95 (59.4) | 447 (75.0) | 1 |
| Obese | 214 (28.3) | 65 (40.6) | 149 (25.0) | |
Statistically significantly associated variables are printed bold
Abbreviations: SD, standard deviation; SES, socio-economic status; BMI, body mass index; OR, odds ratio; CI, confidence interval
*Percentages do not always add up to 100% because of missing values
**Chi-square cannot be calculated since 2 cells (20%) have an expected count of less than 5. * p < .05, ** p < .01, *** p < .001
Associations between need for dietary support, psychological distress, and cancer-specific health-related quality of life among colorectal cancer survivors with overweight/obesity
| Total | Need for support | No need for support | Univariablea | Multivariableb | |
|---|---|---|---|---|---|
| N (%) | N (%) | N (%) | OR (95%CI) | OR (95%CI) | |
| Psychological distress | |||||
| Anxiety | |||||
| Yesc | 115 (15.5) | 43 (27.6) | 72 (12.3) | ||
| No | 626 (84.5) | 113 (72.4) | 513 (87.7) | 1 | 1 |
| Depression | |||||
| Yesc | 124 (16.7) | 45 (28.7) | 79 (13.5) | ||
| No | 619 (83.3) | 112 (71.3) | 507 (86.5) | 1 | 1 |
| Cancer-specific HRQoL | |||||
| Global quality of life | |||||
| Below averaged | 113 (15.1) | 42 (26.8) | 71 (12.1) | 1 | 1 |
| Average | 113 (15.1) | 29 (18.5) | 84 (14.3) | 0.58 (0.33–1.03) | 0.83 0(.42–1.61) |
| Above average | 405 (54.3) | 68 (43.3) | 337 (57.2) | ||
| High | 115 (15.4) | 18 (11.5) | 97 (16.5) | ||
| Physical functioning | |||||
| Below averaged | 125 (18.0) | 45 (28.5) | 90 (15.2) | 1 | 1 |
| Average | 100 (13.4) | 25 (15.8) | 75 (12.7) | 0.67 (0.37–1.19) | 0.62 (0.31–1.24) |
| Above average | 328 (43.8) | 61 (38.6) | 267 (45.2) | ||
| High | 86 (24.8) | 27 (17.1) | 159 (26.9) | ||
| Role functioning | |||||
| Below averaged | 125 (16.7) | 40 (25.3) | 85 (14.4) | 1 | 1 |
| Average | 130 (17.4) | 36 (22.8) | 94 (15.9) | 0.81 (0.48–1.39) | 0.99 (0.53–1.85) |
| Above average | 74 (9.9) | 19 (12.0) | 55 (9.3) | 0.73 (0.39–1.40) | 1.13 (0.53–2.37) |
| High | 419 (56.0) | 62 (39.9) | 356 (60.3) | ||
| Emotional functioning | |||||
| Below averaged | 70 (9.4) | 31 (19.6) | 39 (6.6) | 1 | 1 |
| Average | 62 (8.3) | 12 (7.6) | 50 (8.5) | ||
| Above average | 219 (29.3) | 45 (28.5) | 174 (29.5) | ||
| High | 397(53.1) | 70 (44.3) | 327 (55.4) | ||
| Cognitive functioning | |||||
| Below averaged | 71 (9.5) | 25 (15.8) | 46 (7.8) | 1 | 1 |
| Average | 107 (14.3) | 30 (19.0) | 77 (13.1) | 0.72 (0.38–1.37) | 0.73(0.34–1.59) |
| Above average | 210 (28.1) | 51 (32.3) | 159 (26.9) | 0.59 (0.33–1.05) | 0.89(0.45–1.76) |
| High | 360 (48.1) | 52 (32.9) | 308 (52.2) | ||
| Social functioning | |||||
| Below averaged | 61 (8.2) | 24 (15.4) | 37 (6.3) | 1 | 1 |
| Average | 110 (14.7) | 33 (21.2) | 77 (13.1) | 0.66 (0.34–1.27) | 0.65(0.30–1.37) |
| Above average | 104 (13.9) | 20 (12.8) | 84 (14.2) | ||
| High | 471 (63.1) | 79 (50.6) | 392 (66.4) |
Abbreviations: HRQoL, health-related quality of life; SD, standard deviation; OR, odds ratio; CI, confidence interval
* p < .05
** p < .01
*** p < .001
aUnivariable logistic regression analyses with need for support as dependent variable and a single cancer-specific health-related quality of life variable or psychological distress variable as independent variable
bMultivariable logistic regression analyses with need for support as dependent variable, and independent variables: age, gender (male/female), having a partner (yes/no), having diabetes (yes/no), degree of overweight (overweight/obese), and one cancer-specific health-related quality of life variable or psychological distress variable
cA cut-off score of 8 or higher on anxiety or depression on the Hospital Anxiety and Depression Scale (HADS) is defined as having symptoms of anxiety (yes/no) or depression (yes/no)
d “Below average” represents a score between 0 and 66.6, “average” represents a score between 66.7 and 74.9, “above average” represents a score between 75.0 and 99.9, and “high” represents a score of 100 on the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-CR30)